In the biopharma world, prostaglandins are best known as a target for painkillers. Nonsteroidal anti-inflammatory drugs (NSAIDS) from ibuprofen to Celebrex (celecoxib, Pfizer Inc.) work by inhibiting the production of prostaglandin E2 (PGE2).